General Updates

August 11, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, Fort, G Block, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai 400 051 Scrip Code: 506414 Trading Symbol: FERMENTA Dear Sir, Sub.: Presentation for shareholders at 74th Annual General Meeting (‘AGM’) Please find enclosed herewith the presentation to be made for shareholders at 74th Annual General Meeting of the Company. Kindly take the same on record. Thanking you, Yours faithfully, for Fermenta Biotech Limited Varadvinayak Khambete Company Secretary and Head - Legal CS Membership No: A33861 Encl: As above 74th Annual General Meeting Shareholders 11 August 2026 2025-26 was a year of operating momentum, renewed strategic conviction, capital commitment 74th Annual General Meeting | 2 Talking Points Innovation: Patent, CEP and New Capacity Granted plant-source Vitamin D3 process patent, EDQM CEP for D3 100 SD, and ₹110 crore of new Dahej capacity approved Scale: Record Topline, Strong Operating Leverage Consolidated revenue rose to a record ₹548 crore, up 14% from ₹481 crore in FY25, and 26% excluding real estate Core EBITDA ex-real estate rose 44% to ₹120 crore; PAT of ₹70 crore against a high FY25 base carrying ₹45 crore of one-off real-estate income Focus: From Recovery to Broad-Based Growth Ten straight quarters of positive results, with growth across all three operating businesses Innovation, scale and focus span Fermenta’s financials, operations, strategy 74th Annual General Meeting | 3 Recent Timeline Manufacturing & technology breakthroughs Backward integration & strategic growth ₹ 548 Cr Human nutrition innovations ₹ 481 Cr Plant-source Vitamin D3 & therapeutics 2026 Biocatalysis & green chemistry | global certifications ₹ 407 Cr Granted the Indian ₹ 347 Cr 2025 process patent for plant-source Vitamin ₹ 305 Cr Completed validation D3 (VITADEE Green®) 2022 batches for spray Secured EDQM CEP for Commissioned dried Vitamin D3 Vitamin D3 100 SD, FRK plant in 2024 100,000 IU/g powder opening European Tirupati (Vitamin D3 100 SD) pharmaceutical Commissioned and began markets 2020 premix plant at qualification with Backward Kullu leading global Board approved ₹110 integration of key customers and crore capex for plant- starting material, Commercialized regulators source Vitamin D3, Science-validated innovation, Vitamin K1 using Calcifediol and viz, cholesterol proprietary Began commercial biocatalysis enzymes Acquired 52% stake technology scale production of scale, and focus across in AGD Nutrition plant-source Vitamin Scaled Green USA — renamed Successfully D3 and completed Chemistry, with Fermenta USA LLC transferred plant- validation batches of Penicillin G Acylase source Vitamin D3 plant-source D3 in Oil supplying India’s PLI- Nutrition and green chemistry Launch of spray technology from and spray dried led penicillin revival dried Vitamin D3 R&D to powder for VITADEE Carved out the Feed Grade 500 by manufacturing Green® Environment Division Fermenta Biotech GmbH EU GMP and US FDA Approval from GAIN via slump sale into a certifications for and WFP, reinforcing dedicated subsidiary, Dahej facility our global Fermenta Environment commitment to Solutions Pvt Ltd quality nutrition 74th Annual General Meeting | 4 The Opportunity Unlocking growth: Fermenta’s unique position to meet evolving health and nutrition demands worldwide India Global Innovation Drivers ✓ Preventive health ✓ Nutritional supplements ✓ Plant-source actives awareness ✓ Ageing drives vitamin D ✓ Biocatalysis & green chemistry ✓ Growing middle class ✓ Fortified food markets ✓ Advanced delivery ✓ Govt initiatives / PLI ✓ Clean-label growth ✓ Food fortification ✓ Pet nutrition market ✓ Functional food growth ✓ Prevention over cure ✓ Animal nutrition demand ✓ Green chemistry demand ✓ Pharma & API localisation Industry-wide Trends Regulatory Opportunities ✓ Green innovation ✓ Evolving regulations ✓ New delivery systems ✓ Global standards ✓ Biocatalysis & enzymes ✓ Science-validated efficacy ✓ Supply-chain visibility ✓ Immune health focus 74th Annual General Meeting | 5 Strategy Map Our Mission To harness our expertise in Innovation Chemistry and complex manufacturing at scale, delivering science-validated, leading-class solutions across nutrition, health and green chemistry, while creating lasting value for customers, society and investors Financial Financial Performance and Deliver consistent, industry-leading returns and cash generation Investor Value Optimise asset value and unlock capital from non-core assets Sustain growth through disciplined organic investment and selective acquisitions Maintain a strong, deleveraged balance sheet Sales Customer-Centric Approach Target key sectors: pharma, nutrition, food and beverages, veterinary, and custom premixes Exceed the science-validated quality standards demanded by global industry leaders Deepen strategic relationships with premier brands across health and nutrition Expansion Market Expansion & Extend global leadership in Vitamin D3, including differentiated plant-source D3 Inorganic Growth Deepen the 60-plus country footprint and open new geographies, including the EU via EDQM CEP Pursue selective acquisitions and partnerships that expand capabilities and markets Integrate complementary technologies to accelerate the Innovation Chemistry pipeline Internal Operational Excellence Innovation and Product Development Sustainability and Social Responsibility Process Scale advanced, integrated manufacturing Deploy Innovation Chemistry and R&D to create Advance global health through science-validated across Dahej, Kullu and Tirupati science-validated products preventive nutrition and actives Draw on decades of complex, Broaden the portfolio across vitamins, biocatalysis and Enhance wellbeing and productivity across human and high-value chemistry expertise enzymes, premixes and intermediates animal populations Drive efficiency and margins through Deliver targeted, research-led solutions to specific Lead on sustainability through green chemistry and process innovation and green chemistry customer challenges lower-footprint processes Organizational Capability Development Build research and process capabilities at the frontier of Innovation Chemistry Learning Cultivate cross-functional expertise across sectors, geographies and technologies accelerate growth | diversify the portfolio | strengthen global leadership 74th Annual General Meeting | 6 Manufacturing and R&D Enzymes and APIs including Vitamin D3 Customized premix plant Kullu Multiple global regulatory certifications Dedicated Vitamin D3 with Himachal Pradesh backward integration for cholesterol Collaboration with toll Multiple global regulatory Dahej manufacturer for Vitamin Germany certifications Gujarat D3 500 feedgradepowder Thane Corporate HQ + R&D excellence center Maharashtra Pilot plant for process development Innovation hub for new product initiatives Tirupati Fortified Rice Kernel (FRK) enriched with Quality control and validation laboratories Andhra Pradesh iron, vitamin B12, and folic acid Regulatory and compliance center Compliant with FSSAI guidelines for rice fortification Certified by WFP 100+ 15+ Scientists & Engineers Key Certifications Strategic Manufacturing Footprint Breakthrough Capabilities at Global Scale 75+ 400+ Global Trust Indicators Years of Expertise Global Customers 74th Annual General Meeting | 7 Strategic Partnership Ecosystem The Collaboration Strategic Value Global healthcare company Vitamin D awareness campaigns Extends our reach to healthcare specializing in diagnostics, professionals and patients Print and audiovisual educational materials medical devices, and nutrition Premier food technology Fortification of biscuits and juices with Adds government-backed credibility institute under Ministry of Food VITADEE Green® to our fortification initiatives Processing Industries Development of Fortifie [Showing first 8,000 characters — download PDF for full document]